Last reviewed · How we verify
DA-7503 Multiple dose
At a glance
| Generic name | DA-7503 Multiple dose |
|---|---|
| Sponsor | Dong-A ST Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DA-7503 Multiple dose CI brief — competitive landscape report
- DA-7503 Multiple dose updates RSS · CI watch RSS
- Dong-A ST Co., Ltd. portfolio CI